Zimmer Biomet (NYSE:ZBH) updated its FY 2026 earnings guidance. The company provided EPS guidance of 8.470-8.590 for the period, compared to the consensus estimate of 8.480. The company also issued revenue guidance of $8.6 billionillion-$8.6 billionillion, compared to the consensus estimate of $8.5 billionillion.